Key Takeaways
- • Gooch & Housego's £346 million ($470 million) acquisition by Arlington Capital has cleared antitrust review, with the regulatory waiting period expiring as of September 2, 2026.
- • The optics technology provider was advised by Burges Salmon LLP, while Arlington Capital was represented by Kirkland & Ellis LLP in the transaction.
- • Expiration of the antitrust waiting period removes a significant regulatory barrier, though final deal completion remains subject to other closing conditions.
- • Arlington Capital's acquisition of the optics specialist represents a notable private equity entry into the precision technology sector.
Summary
Gooch & Housego, a provider of optics technology solutions, has successfully navigated antitrust regulatory review for its proposed acquisition by private equity firm Arlington Capital. The deal, valued at £346 million (approximately $470 million), reached a critical milestone on September 2, 2026, when the mandatory antitrust waiting period expired without intervention from competition authorities.
The transaction was facilitated by legal counsel from two major law firms: Burges Salmon LLP advised Gooch & Housego, while Kirkland & Ellis LLP guided Arlington Capital through the acquisition process. The expiration of the antitrust waiting period indicates that relevant regulatory bodies found no competitive concerns sufficient to block or substantially condition the transaction. This represents a significant procedural advancement for the deal, removing what is typically one of the most material regulatory hurdles in cross-border or substantial domestic acquisitions.
While the clearance of the antitrust waiting period is a major step forward, the transaction remains subject to customary closing conditions and any remaining regulatory approvals. The timing of final deal completion has not been disclosed in available reports. The acquisition underscores continued private equity interest in the precision optics and technology sectors, particularly in specialized industrial applications where Arlington Capital appears to be positioning itself for growth.
The transaction was facilitated by legal counsel from two major law firms: Burges Salmon LLP advised Gooch & Housego, while Kirkland & Ellis LLP guided Arlington Capital through the acquisition process. The expiration of the antitrust waiting period indicates that relevant regulatory bodies found no competitive concerns sufficient to block or substantially condition the transaction. This represents a significant procedural advancement for the deal, removing what is typically one of the most material regulatory hurdles in cross-border or substantial domestic acquisitions.
While the clearance of the antitrust waiting period is a major step forward, the transaction remains subject to customary closing conditions and any remaining regulatory approvals. The timing of final deal completion has not been disclosed in available reports. The acquisition underscores continued private equity interest in the precision optics and technology sectors, particularly in specialized industrial applications where Arlington Capital appears to be positioning itself for growth.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.